Are Analysts Too Bullish On Genmab ADR (GMAB)

Genmab ADR (NASDAQ:GMAB) currently has a daily average trading volume of 569.20K but it saw 841740 shares traded in last market. With a market cap of 18.17B USD, the company’s current market price of $27.88 came falling about -0.21 while comparing to the previous closing price of $27.94. In past 52 weeks, the stock remained buoying in the range of price level as high as $42.72 and as low as $24.53.

Taking a look at 20-day trading activity of Genmab ADR (GMAB) gives us an average price of $26.30, while its current price level is -34.74% below from 52-week high level whereas it is 13.66% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $27.29 while that of 200 days or SMA-200 reads an average of $29.34. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.59% during that period while stretching the period over a month that decreases to 1.32%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 63.73 which implies that the stock is in neutral territory.

BMO Capital Markets upgraded its recommendation for the stock as a “Outperform” from “Market Perform” on February 23, 2024 while assigning a price target range of $46-$48.

Over the week, GMAB’s stock price is moving 3.91% up while it is 7.98% when we observe its performance for the past one month. Year-to-date it is -12.44% down and over the past year, the stock is showing a downside performance of -29.91%.

Currently, Genmab ADR’s total number of outstanding shares is 653.30M. Company’s return on investment (ROI) stands at 16.41% and return on equity (ROE) at 18.32%. It has a price to earnings ratio (P/E ratio) of 23.12 while having a 19.17 of forward P/E ratio. Stock’s beta reads 0.97. Stock has a price to book (P/B) ratio of 3.86 while price to sale or P/S ratio amounts to 7.03. Its return on asset (ROA) is 16.30% on average.